Cutaneous adverse reactions to anti-PD-1 treatment-A systematic review

被引:32
作者
Simonsen, Anne Birgitte [1 ]
Kaae, Jeanette [1 ]
Ellebaek, Eva [2 ]
Svane, Inge Marie [2 ]
Zachariae, Claus [1 ]
机构
[1] Univ Copenhagen, Herlev & Gentofte Hosp, Dept Dermatol & Allergy, Copenhagen, Denmark
[2] Univ Copenhagen, Herlev & Gentofte Hosp, Dept Oncol, Copenhagen, Denmark
关键词
anti-PD-1; cutaneous adverse reaction; dermatology; immunotherapy; oncology; IMMUNE CHECKPOINT BLOCKADE; STEVENS-JOHNSON SYNDROME; PROGRAMMED CELL DEATH-1; METASTATIC MELANOMA; NIVOLUMAB THERAPY; LICHEN-PLANUS; PEMBROLIZUMAB THERAPY; LUNG-CANCER; PSORIASIFORM ERUPTION; DRUG ERUPTION;
D O I
10.1016/j.jaad.2020.04.058
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The use of the humanized monoclonal anti-programmed cell death 1 antibodies pembrolizumab and nivolumab as potent anticancer therapies is rapidly increasing. However, since their approval, numerous cases of cutaneous reactions have been reported. Cutaneous adverse reactions to these agents have yet to be fully characterized and range from nonspecific eruptions to recognizable skin manifestations, which may be localized and vary from mild to life threatening. This systematic review article provides an overview of the various adverse cutaneous reactions to pembrolizumab and nivolumab therapy and offers suggestions for their management.
引用
收藏
页码:1415 / 1424
页数:10
相关论文
共 133 条
[71]   Immunotherapy-induced sarcoidosis in patients with melanoma treated with PD-1 checkpoint inhibitors: Case series and immunophenotypic analysis [J].
Lomax, Anna J. ;
McGuire, Helen M. ;
McNeil, Catriona ;
Choi, Clara J. ;
Hersey, Peter ;
Karikios, Deme ;
Shannon, Kerwin ;
van Hal, Sebastian ;
Carr, Urszula ;
Crotty, Anne ;
Gupta, Sandeep K. ;
Hollingsworth, Jane ;
Kim, Haewon ;
Fazekas de St Groth, Barbara ;
McGill, Neil .
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2017, 20 (09) :1277-1285
[72]   Bullous pemphigoid-like reaction in a patient with metastatic melanoma receiving pembrolizumab and previously treated with ipilimumab [J].
Lomax, Anna J. ;
Ge, Ludi ;
Anand, Sunaina ;
McNeil, Catriona ;
Lowe, Patricia .
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2016, 57 (04) :333-335
[73]   A Case of Nivolumab-Induced Bullous Pemphigoid: Review of Dermatologic Toxicity Associated with Programmed Cell Death Protein-1/Programmed Death Ligand-1 Inhibitors and Recommendations for Diagnosis and Management [J].
Lopez, Adriana T. ;
Geskin, Larisa .
ONCOLOGIST, 2018, 23 (10) :1119-1126
[74]  
Maarouf M, 2018, DERMATOL ONLINE J, V24
[75]   Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti-programmed cell death 1 therapy [J].
Marano, A. L. ;
Clarke, J. M. ;
Morse, M. A. ;
Shah, A. ;
Barrow, W. ;
Selim, M. A. ;
Hall, R. P., III ;
Cardones, A. R. .
BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 (03) :580-583
[76]   Exacerbation of Psoriasis During Nivolumab Therapy for Metastatic Melanoma [J].
Matsumura, Natsuko ;
Ohtsuka, Mikio ;
Kikuchi, Nobuyuki ;
Yamamoto, Toshiyuki .
ACTA DERMATO-VENEREOLOGICA, 2016, 96 (02) :259-260
[77]   Pembrolizumab-Related Sarcoid-Like Reaction Presenting as Reactivation of Quiescent Scars [J].
McKenna, Mary Clare ;
Molloy, Kevin ;
Crowther, Stephen ;
Feeney, John ;
Gillis, Amy ;
Connolly, Maureen ;
Kelleher, Fergal .
JOURNAL OF ONCOLOGY PRACTICE, 2018, 14 (03) :200-+
[78]   Vitiligo: an evidence-based update. Report of the 13th Evidence Based Update Meeting, 23 May 2013, Loughborough, UK [J].
Meredith, F. ;
Abbott, R. .
BRITISH JOURNAL OF DERMATOLOGY, 2014, 170 (03) :565-570
[79]   Bullous pemphigoid [J].
Miyamoto, Denise ;
Santi, Claudia Giuli ;
Aoki, Valeria ;
Maruta, Celina Wakisaka .
ANAIS BRASILEIROS DE DERMATOLOGIA, 2019, 94 (02) :133-146
[80]   Cutaneous autoimmune effects in the setting of therapeutic immune checkpoint inhibition for metastatic melanoma [J].
Mochel, Mark C. ;
Ming, Michael E. ;
Imadojemu, Sotonye ;
Gangadhar, Tara C. ;
Schuchter, Lynn M. ;
Elenitsas, Rosalie ;
Payne, Aimee S. ;
Chu, Emily Y. .
JOURNAL OF CUTANEOUS PATHOLOGY, 2016, 43 (09) :787-791